<DOC>
	<DOC>NCT01309451</DOC>
	<brief_summary>The investigators hypothesize that a combination treatment with Avastin and Ozurdex will result in a more rapid improvement of visual acuity compared to the use of Avastin alone.</brief_summary>
	<brief_title>Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Male or female age 18 years or older Type 1 or type 2 diabetes BCVA score of &gt;24 and &lt;78 letters Presence of DME defined as Optical Coherence Tomography Center Subfield Thickness (OCT CST) &gt;250microns AntiVEGF intravitreal treatment in last 4 weeks Intravitreal steroid treatment in the last 8 weeks PRP or Focal laser in last 4 months Active iris neovascularization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>diabetic macular edema</keyword>
	<keyword>DME</keyword>
</DOC>